Efficacy and Safety of Bleselumab in Preventing the Recurrence of Primary Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Phase 2a, Randomized, Multicenter Study - Concepedia

Concepedia

Publication | Open Access

Efficacy and Safety of Bleselumab in Preventing the Recurrence of Primary Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Phase 2a, Randomized, Multicenter Study

DOI Full Paper Access

11

Citations

11

References

2024

Year

Jun Shoji, William C. Goggins, Jason R. Wellen, Patrick N. Cunningham, Olwyn Johnston, Shirley Chang, Kim Solez, Vicki Santos, Tami J. Larson, Masahiro Takeuchi,

Transplantation

Abstract

In at-risk kidney transplant recipients, bleselumab numerically reduced proteinuria occurrence versus SOC, but no notable difference in occurrence of biopsy-proven rFSGS was observed.

References

	Year	Citations

Page 1